Why the study?
Although transcriptional and signaling factors in the second heart field contribute to cardiac development, the associations of intronic gene variants in this field with congenital heart disease remain not understood.
Are intronic polymorphisms in second heart field genes associated with an increased risk of congenital heart disease in a Chinese population?
Are intronic polymorphisms in second heart field genes associated with an increased risk of congenital heart disease in a Chinese population?
Intronic SNPs in transcriptional and signaling factors of the second heart field are significantly associated with increased risk of various congenital heart disease types in a Chinese population.
SHF intronic variants may confer CHD susceptibility; hypothesis-generating and requires replication before any clinical consideration.
Transcriptional factors and signaling factors in the second heart field (SHF) contribute to cardiac development. However, the associations of intronic gene variants in the SHF with congenital heart disease (CHD) remain ununderstood. Ten single nucleotide polymorphisms (SNPs) from our previous sequencing data were selected and then genotyped in 383 CHD patients and 384 healthy controls in a Chinese population. Genotype analyses revealed that minor alleles in TBX1: rs12165908 C > G [odds ratio (OR) = 2.64; 95% confidence interval (CI) = 1.87–3.73, p = 3.03 × 10−8] and GATA6: rs143085291 C > T (OR = 2.49; 95% CI = 1.18–5.29, p = 0.01) increased CHD risk significantly. Meanwhile, FGF10: rs78454549 T > C and GATA4: rs13275657 A>G polymorphisms were significantly associated with increased risk of simple CHDs. The minor allele C in GATA4: rs17153694 T > C increased the risk of tetralogy of Fallot, whereas minor alleles in TBX1: rs41298006 G>A, FGF10: rs75629618 C>T, FGF10: rs10461755 G>A, FGF10: rs75632187 A>G, and FGF10: rs12518964 G > A were associated with increased risk of single ventricle. The minor allele T in rs143085291 in GATA6 enhancer decreased the transcription level in luciferase assay. Our findings suggest that intronic SNPs in transcriptional factors and signaling factors in the SHF are significantly associated with increased risk of different CHD types.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: